Torrent Pharmaceuticals Limited Extract Export Data — India (DGFT 2022–2026)

Name: Torrent Pharmaceuticals Limited Extract Export Records India — #13 Exporter, 4 Shipments, $200.0K FOB USD (DGFT 2022–2026)
Creator: TransData Nexus
Published: 2026-05-01T00:00:00Z
License: https://transdatanexus.com/terms-and-conditions

Suresh Sormare

Extract

India Pharmaceutical Trade Intelligence

$12.1M292 Suppliers109 CountriesHS 30049099

ExportsIndia → PHILIPPINES13.7%India → UNITED ARAB9.8%

#1 Supplier: DABUR INDIA #1 Buyer: REGENCY PHARMA

Torrent Pharmaceuticals Limited — Extract Exporter #13 | $200.0K Trade Value | TransData Nexus | TransData Nexus

Torrent Pharmaceuticals Limited — Extract Exporter Profile

Indian Pharmaceutical Exporter · #13 for Extract · $200.0K export value · DGFT Verified

Torrent Pharmaceuticals Limited is the #13 Indian exporter of Extract with $200.0K in export value and 4 verified shipments. Torrent Pharmaceuticals Limited holds a 1.6% market share in Extract exports across 1 countries. The company exports 43 pharmaceutical products worth $219.4M across 18 therapeutic categories.

Torrent Pharmaceuticals Limited — Extract Export Profile: Buyers & Destinations

Torrent Pharmaceuticals Limited Extract export treemap — buyers and destination countries | TransData Nexus

Where Does India Export Extract?

Country	Value	Shipments	Share
PHILIPPINES	$1.3M	25	13.6%
UNITED ARAB EMIRATES	$1.2M	260	12.9%
MYANMAR	$999.7K	26	10.9%
SINGAPORE	$973.3K	129

Who Are the Top Buyers of Extract from India?

Buyer	Country	Value	Orders
REGENCY PHARMA LIMITED	MAURITIUS	$806.6K	220
MEDI MYANMAR GROUP LTD	MYANMAR	$550.0K	11
UNAHCO INC	PHILIPPINES	$500.0K	10
INOVA PHARMACEUTICALS(SINGAPORE) PT	SINGAPORE	$402.1K	44
NATURELLE LLC	UNITED ARAB EMIRATES	$300.2K	25
DAVENBEN ENTERPRISES CORP	PHILIPPINES	$200.0K	4
ELBE PHARMA NIGERIA LIMITED	NIGERIA	$200.0K	4
DAILY - NEED INDUSTRIES LIMITED	NIGERIA	$194.7K	4
M/S DAVENBEN ENTERPRISES CORP	PHILIPPINES	$150.0K	3
MEDI MYANMAR GROUP LTD.	MYANMAR	$150.0K	3

India's Extract is purchased by 591 buyers worldwide. The top buyer is REGENCY PHARMA LIMITED (MAURITIUS), followed by MEDI MYANMAR GROUP LTD and UNAHCO INC.

How Does Torrent Pharmaceuticals Limited Compare to Nearest Extract Exporters?

Exporters ranked immediately above and below #13 by export value

#	Supplier	Export Value	Shipments	Countries	Avg/Shipment
14	NIROGAM INDIA PRIVATE LIMITED	$216.2K	79	1	$2.7K
15	SUN PHARMACEUTICAL INDUSTRIES LIMITED	$211.3K	18	1	$11.7K
13	TORRENT PHARMACEUTICALS LIMITED ★	$200.0K	4	1	$50.0K
10	OLIVE HEALTH CARE	$150.0K	3	1	$50.0K

Torrent Pharmaceuticals Limited ranks #13 among 292 Indian Extract exporters. Average shipment value of $50.0K compared to the market average of $22.5K. The closest competitors by value are NIROGAM INDIA PRIVATE LIMITED and SUN PHARMACEUTICAL INDUSTRIES LIMITED.

Which Indian Ports Ship Extract Exports?

Port	Shipments	% Share
SAHAR AIR	385	17.9%
SAHAR AIR CARGO ACC (INBOM4)	238	11.1%
Bombay Air	128	6.0%
DELHI AIR	124	5.8%
NHAVA SHEVA SEA (INNSA1)	117	5.4%
DELHI AIR CARGO ACC (INDEL4)	101	4.7%
Delhi Air	82	3.8%
BANGALORE ICD (INWFD6)	74	3.4%

Geopolitical & Trade Policy Impact on Torrent Pharmaceuticals Limited's Extract Exports

The global pharmaceutical export landscape is currently navigating a series of geopolitical challenges that have direct implications for Indian exporters like Torrent Pharmaceuticals.

The ongoing Israel-Iran tensions have led to disruptions in the Red Sea shipping routes, a critical corridor for Indian pharmaceutical exports to the Middle East and North Africa (MENA) region. Maritime carriers have suspended bookings and rerouted shipments via the Cape of Good Hope, resulting in longer transit times and increased shipping costs. These disruptions are particularly concerning for time-sensitive pharmaceutical products, as extended lead times can affect product efficacy and shelf life. (pharmaceuticalcommerce.com)

In the United States, recent tariff policies have introduced additional complexities. The U.S. administration's imposition of broad tariffs on imports from over 60 countries, including India, has raised concerns about the competitiveness of Indian pharmaceutical products in the U.S. market. While health products have been exempted from these tariffs, the potential for future policy changes necessitates vigilance. (apnews.com)

The European Union's regulatory landscape is also evolving, with stringent compliance requirements under the Falsified Medicines Directive (FMD). Indian exporters must ensure adherence to these regulations to maintain market access. Non-compliance could result in significant market share losses in the EU, a key export destination for Torrent Pharmaceuticals.

Torrent Pharmaceuticals Limited — Regulatory Compliance & Quality Standards

Quality compliance remains a critical focus for Indian pharmaceutical exporters. The U.S. Food and Drug Administration (FDA) has intensified inspections of Indian manufacturing facilities, conducting over 200 inspections in 2023, with plans to increase this number in 2024. This heightened scrutiny underscores the importance of adhering to Good Manufacturing Practices (GMP) to ensure product quality and maintain export eligibility. (fact.net.in)

Torrent Pharmaceuticals has proactively addressed these regulatory challenges by investing in quality control systems and infrastructure. The company's commitment to compliance is evident in its consistent financial performance and sustained market presence. However, the broader Indian pharmaceutical sector continues to grapple with issues related to counterfeit drugs and quality concerns, which can impact the reputation of even compliant companies.

Research Methodology & Data Transparency

Suresh Sormare

Verified Author

Pharmaceutical Export-Import Analyst & Trade Intelligence Expert

Suresh Sormare is a pharmaceutical export-import analyst with deep expertise in Indian Customs (DGFT) data, HS code classification, and global pharmaceutical supply chains. His analysis covers 10M+ shipment records across 150+ countries and is used by manufacturers, procurement agencies, and trade consultants worldwide. Suresh specializes in identifying verified suppliers and buyers from customs records, mapping bilateral pharmaceutical trade corridors, analyzing tariff structures and regulatory frameworks across 170+ destination markets, and benchmarking competitive positioning for finished pharmaceutical formulations. His methodology combines granular customs transaction data with regulatory intelligence from FDA, EMA, WHO, CDSCO, and 40+ national drug authorities to deliver actionable trade insights for the pharmaceutical formulations sector.

linkedin.com/in/sureshsormare

Primary Data Source

All trade data is sourced from Indian Customs (DGFT) official shipping bill records — the authoritative government database for India's pharmaceutical trade. Each verified record contains exporter name, consignee (buyer) name, detailed product description, quantity, declared FOB value (USD), port of loading, destination country, and shipment date.

Analysis Methodology

1.Product Matching: Extract shipments identified using fuzzy matching on DGFT product description fields, validated against Indian Pharmacopoeia nomenclature.
2.Supplier Identification: Torrent Pharmaceuticals Limited matched across shipments using name normalization, accounting for company name formatting variations.
3.Statistical Normalization: Shipment values are statistically normalized to ensure accurate market share representation. This removes the impact of unusually large one-off transactions that could distort company rankings.

Government-Sourced Data

Official DGFT customs records

Transparent Methodology

Calculations fully disclosed above

Global Coverage

Exports to 109+ countries, 591+ buyers

Expert-Reviewed

Analyzed by pharmaceutical trade specialists

Extract

Extract

Torrent Pharmaceuticals Limited — Extract Exporter Profile

Torrent Pharmaceuticals Limited — Extract Export Profile: Buyers & Destinations

Where Does India Export Extract?

Who Are the Top Buyers of Extract from India?

What Is India's Total Extract Export Value and How Much Does Torrent Pharmaceuticals Limited Contribute?

What Is the Average Shipment Value for Torrent Pharmaceuticals Limited's Extract Exports?

How Does Torrent Pharmaceuticals Limited Compare to Other Indian Extract Exporters?

Regulatory Requirements: Exporting Extract to Key Markets

United States — FDA

How Does Torrent Pharmaceuticals Limited Compare to Nearest Extract Exporters?

Which Indian Ports Ship Extract Exports?

Geopolitical & Trade Policy Impact on Torrent Pharmaceuticals Limited's Extract Exports

Torrent Pharmaceuticals Limited — Regulatory Compliance & Quality Standards

About Torrent Pharmaceuticals Limited

Market Intelligence

Official References & Regulatory Resources

Research Methodology & Data Transparency

Suresh Sormare

Primary Data Source

Analysis Methodology

Get Extract Export Data from Torrent Pharmaceuticals Limited

Extract Stats

Company Overview

Top Products by Torrent Pharmaceuticals Limited

Related Analysis

Need Detailed Export Data?

Data Source